ARENTFOX SCHIFF LLP for PHARVARIS PHARMACEUTICALS, INC. (FKA PHARVARIS, INC.)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production
| Lobbyist | Covered position, as disclosed |
|---|---|
| STARSHINE CHUN New | Executive Assistant/Deputy Scheduler, Sen. Brian Schatz (2021-2023) |
| PHILIP ENGLISH New | U.S. Representative (1995-2009) |
| LAURA EUGSTER DOYLE New | Legislative Director, Rep. Philip English (1998-2002) |
| KELSEY GRISWOLD-BERGER New | Leg Asst, Sen. Burr (2021-2023); Leg Dir, Rep. C. Smith (2018-2021); Leg Dir, Rep. Pittenger (2018); Leg Dir, Rep. Blum (2017-2018); Leg Asst, Rep. Perry (2015-2017); Leg Asst (2014-2015), Leg Corr/Press Asst (2011-2014), Staff Asst (2011), Rep. Reed |
| DANIEL SJOSTEDT New | Staff Assistant, Rep. Jeff Fortenberry (2016-2017) |
| OLIVER SPURGEON III New | Legislative Correspondent, Rep. Hank Johnson (2009-2015); Staff Assistant, Rep. Hank Johnson (2007-2009) |
Medicare/Medicaid MMM
Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production
| Lobbyist | Covered position, as disclosed |
|---|---|
| STARSHINE CHUN New | Executive Assistant/Deputy Scheduler, Sen. Brian Schatz (2021-2023) |
| PHILIP ENGLISH New | U.S. Representative (1995-2009) |
| LAURA EUGSTER DOYLE New | Legislative Director, Rep. Philip English (1998-2002) |
| KELSEY GRISWOLD-BERGER New | Leg Asst, Sen. Burr (2021-2023); Leg Dir, Rep. C. Smith (2018-2021); Leg Dir, Rep. Pittenger (2018); Leg Dir, Rep. Blum (2017-2018); Leg Asst, Rep. Perry (2015-2017); Leg Asst (2014-2015), Leg Corr/Press Asst (2011-2014), Staff Asst (2011), Rep. Reed |
| DANIEL SJOSTEDT New | Staff Assistant, Rep. Jeff Fortenberry (2016-2017) |
| OLIVER SPURGEON III New | Legislative Correspondent, Rep. Hank Johnson (2009-2015); Staff Assistant, Rep. Hank Johnson (2007-2009) |
Pharmacy PHA
Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production
| Lobbyist | Covered position, as disclosed |
|---|---|
| STARSHINE CHUN New | Executive Assistant/Deputy Scheduler, Sen. Brian Schatz (2021-2023) |
| PHILIP ENGLISH New | U.S. Representative (1995-2009) |
| LAURA EUGSTER DOYLE New | Legislative Director, Rep. Philip English (1998-2002) |
| KELSEY GRISWOLD-BERGER New | Leg Asst, Sen. Burr (2021-2023); Leg Dir, Rep. C. Smith (2018-2021); Leg Dir, Rep. Pittenger (2018); Leg Dir, Rep. Blum (2017-2018); Leg Asst, Rep. Perry (2015-2017); Leg Asst (2014-2015), Leg Corr/Press Asst (2011-2014), Staff Asst (2011), Rep. Reed |
| DANIEL SJOSTEDT New | Staff Assistant, Rep. Jeff Fortenberry (2016-2017) |
| OLIVER SPURGEON III New | Legislative Correspondent, Rep. Hank Johnson (2009-2015); Staff Assistant, Rep. Hank Johnson (2007-2009) |
Trade (domestic/foreign) TRD
Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production
| Lobbyist | Covered position, as disclosed |
|---|---|
| STARSHINE CHUN New | Executive Assistant/Deputy Scheduler, Sen. Brian Schatz (2021-2023) |
| PHILIP ENGLISH New | U.S. Representative (1995-2009) |
| LAURA EUGSTER DOYLE New | Legislative Director, Rep. Philip English (1998-2002) |
| KELSEY GRISWOLD-BERGER New | Leg Asst, Sen. Burr (2021-2023); Leg Dir, Rep. C. Smith (2018-2021); Leg Dir, Rep. Pittenger (2018); Leg Dir, Rep. Blum (2017-2018); Leg Asst, Rep. Perry (2015-2017); Leg Asst (2014-2015), Leg Corr/Press Asst (2011-2014), Staff Asst (2011), Rep. Reed |
| DANIEL SJOSTEDT New | Staff Assistant, Rep. Jeff Fortenberry (2016-2017) |
| OLIVER SPURGEON III New | Legislative Correspondent, Rep. Hank Johnson (2009-2015); Staff Assistant, Rep. Hank Johnson (2007-2009) |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| PHARVARIS N.V. | Netherlands | Netherlands | 100.0% | — |
| PHARVARIS GMBH | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.